DeepMind spin-off aims to halve drug discovery times following Big Pharma deals

Chief of Google’s AI unit and Isomorphic Labs spells out targets following $3bn Eli Lilly-Novartis partnerships

Demis Hassabis, who founded Google DeepMind and runs its drugs offshoot Isomorphic Labs, says the goal is to cut initial stage from about 5 years t